<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03185234</url>
  </required_header>
  <id_info>
    <org_study_id>Uni-Koeln-3033</org_study_id>
    <secondary_id>U1111-1195-2536</secondary_id>
    <secondary_id>DRKS00012292</secondary_id>
    <nct_id>NCT03185234</nct_id>
  </id_info>
  <brief_title>Rehabilitating (Stroke-induced) Apraxia With Direct Current Stimulation</brief_title>
  <acronym>RAdiCS</acronym>
  <official_title>Therapeutischer Einsatz Der Schwachen Gleichstromstimulation (tDCS) Bei Motorisch-kognitiven Defiziten Nach Schlaganfall</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the clinical trial is to investigate whether weak transcranial direct&#xD;
      current stimulation (tDCS) can ameliorate the motor cognitive deficit apraxia during stroke&#xD;
      rehabilitation. Stroke patients with apraxia will either receive a real stimulation or a sham&#xD;
      stimulation (placebo) for 10 minutes at a time on 5 consecutive days during their in-patient&#xD;
      stay in a rehabilitation center. Additionally, motor tasks are performed before and after the&#xD;
      stimulation. The effect of the weak current stimulation on motor function is assessed 3-4&#xD;
      days after the last stimulation and 3 months after enrollment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite the high incidence of the motor cognitive deficit apraxia after left-hemispheric&#xD;
      stroke, evidence-based therapies do not exist. This randomized controlled clinical trial&#xD;
      (RCT) investigates whether anodal transcranial direct current stimulation (tDCS) as an add-on&#xD;
      therapy during neuro-rehabilitation can ameliorate apraxic deficits in patients with left&#xD;
      hemisphere stroke. Therefore, anodal tDCS is applied over the parietal cortex of the left,&#xD;
      lesioned hemisphere with an intensity of 2 mA for 10 minutes at a time on 5 consecutive days&#xD;
      in combination with motor tasks before and after the stimulation. The effect of the&#xD;
      stimulation is compared to a sham stimulation. Moreover, application of a pre-programmed&#xD;
      study mode ensures a double-blind study design (patient and investigator). The performance in&#xD;
      the apraxia test KAS (Cologne Apraxia Screening) 3-4 days after the last stimulation,&#xD;
      compared to baseline, serves as primary endpoint of the study. Secondary endpoints are&#xD;
      evaluated using various apraxia tests, motor tests and neuropsychological tests 3-4 days&#xD;
      after the last stimulation and 3 months after enrollment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 23, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>KAS (Cologne Apraxia Screening)</measure>
    <time_frame>3-4 days after stimulation</time_frame>
    <description>Degree of apraxia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>KAS (Cologne Apraxia Screening)</measure>
    <time_frame>3 months after enrollment</time_frame>
    <description>Degree of apraxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Goldenberg Imitation</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Degree of apraxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>de Renzi Imitation</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Degree of apraxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>de Renzi actual tool use</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Degree of apraxia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test (ARAT)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Jebsen Taylor Hand Function Test (JTHFT)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gripforce (Vigorimeter)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strength of hands (MRC)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Motor function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institute of Health Stroke Scale (NIHSS)</measure>
    <time_frame>enrollment</time_frame>
    <description>Impairment by stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Ranking Scale (mRS)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Impairment by stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aphasia Check List (ACL-K)</measure>
    <time_frame>3-4 days after stimulation, and 3 months after enrollment</time_frame>
    <description>Aphasia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Stroke</condition>
  <condition>Apraxia</condition>
  <arm_group>
    <arm_group_label>Real tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anodal tDCS at an intensity of 2 mA is applied for 10 minutes at a time on 5 consecutive days. The anodal electrode is placed over the left parietal cortex (P3 in 10/20 EEG) of the lesioned hemisphere, the cathodal electrode is located supraorbital on the right side. Motor tasks are performed before and after the stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham stimulation is applied for 10 minutes at a time on 5 consecutive days. One electrode is placed over the left parietal cortex (P3 in 10/20 EEG) of the lesioned hemisphere and a second electrode supraorbital on the right side. Motor tasks are performed before and after the stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>anodal tDCS</intervention_name>
    <description>2 mA, 10 min, 5 sessions</description>
    <arm_group_label>Real tDCS</arm_group_label>
    <other_name>neuroConn DCS, model no. 008</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham tDCS</intervention_name>
    <description>sham stimulation, 10 min, 5 sessions</description>
    <arm_group_label>Sham tDCS</arm_group_label>
    <other_name>neuroConn DCS, model no. 008</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  left hemispheric ischemic stroke in the subacute/ chronic phase (&gt;10 days and &lt;180&#xD;
             days post-stroke)&#xD;
&#xD;
          -  clinical confirmation of apraxia by KAS (Cologne Apraxia Screening), Cut-off ≤ 76/ 80&#xD;
             points;&#xD;
&#xD;
          -  age 18 - 90 years;&#xD;
&#xD;
          -  written Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy, breastfeeding and women without exclusion of pregnancy&#xD;
&#xD;
          -  patients with clinical manifestation of a stroke prior to the index-stroke&#xD;
&#xD;
          -  malignant disease with affection of central nervous system&#xD;
&#xD;
          -  life expectancy &lt;12 months&#xD;
&#xD;
          -  current addiction to alcohol or drugs or other addictive disease (exception: nicotine)&#xD;
&#xD;
          -  current clinically manifest psychiatric disorders, such as schizophrenia or severe&#xD;
             depressive episode&#xD;
&#xD;
          -  epileptic seizure within the past two years&#xD;
&#xD;
          -  continuous medication during the intervention phase with benzodiazepine,&#xD;
             antipsychotics of high potential and anti-epileptic drugs taken for prophylaxis of&#xD;
             epileptic seizures&#xD;
&#xD;
          -  enrollment in other studies with brain stimulation in the time period after the index&#xD;
             stroke&#xD;
&#xD;
          -  heart pacemaker&#xD;
&#xD;
          -  electrodes for deep brain stimulation or other metal implants in the head (expected&#xD;
             are dental fillings and inlays)&#xD;
&#xD;
          -  craniectomy or trepanation&#xD;
&#xD;
          -  vulnerable skin lesions at electrode positions&#xD;
&#xD;
          -  poor motivation/ cooperation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gereon R. Fink, Univ-Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Cologne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rehabilitationszentrum Godeshöhe e.V.</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53177</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MediClin Fachklinik Rhein/Ruhr für Neurologie</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45219</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 31, 2017</study_first_submitted>
  <study_first_submitted_qc>June 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Gereon R. Fink</investigator_full_name>
    <investigator_title>Univ.-Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>tDCS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Apraxias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

